| Unique ID issued by UMIN | UMIN000063712 |
|---|---|
| Receipt number | R000072909 |
| Scientific Title | A verification study of the effects of test food consumption on beauty: an open-label study |
| Date of disclosure of the study information | 2026/11/20 |
| Last modified on | 2026/11/20 17:56:11 |
A verification study of the effects of test food consumption on beauty: an open-label study
A verification study of the effects of test food consumption on beauty: an open-label study
A verification study of the effects of test food consumption on beauty: an open-label study
A verification study of the effects of test food consumption on beauty
| Japan |
Healthy Japanese
| Not applicable | Adult |
Others
NO
To verify the effect of the test food consumption on skin condition in healthy Japanese.
Efficacy
Confirmatory
Pragmatic
Not applicable
1. The measured value of transepidermal water loss (TEWL) at 8 weeks after the intervention (8w)
1. The measured value of skin surface moisture at 8w
2. The measured values of ceramide levels at 8w
3. The measured values of Visual Analogue Scale (VAS) for "I am concerned about dry skin", "I am concerned about skin dullness and uneven tone", "I am concerned about skin pores", "I am concerned about fine wrinkles around the eyes", "I am concerned about skin oiliness and shine", "I am concerned about skin redness", "I am concerned about skin roughness and texture", "I am concerned about stiff skin and skin tightness", "I feel my skin has no firmness and less elasticity", "I feel my skin has no moisture" at 8w
4. Individuals who experienced adverse events
5. Individuals whose urinalysis and peripheral blood test values were within the reference range at screening but became outside the reference range after intervention
6. Physical measurements, urinalysis, and peripheral blood test
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Educational,Counseling,Training
| Food |
<Duration>
8 weeks
<Test product>
Test food: Test food containing vitamin C, ceramide, and niacinamide
Net weight: 6.2 g per packet
Main ingredients per packet: 3,000 microgram of glucosylceramide derived from rice, 1,000 mg of vitamin C, and 40 mg of niacinamide
<Administration>
Consume one packet per day, either as it is or with water or warm water. Take it on an empty stomach, such as before breakfast or before going to bed.
*If a dose is missed, it should be consumed as soon as remembered. The daily dose should be consumed within the same day and should not be carried over to the following day.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Japanese
2. Men or women
3. Adults
4. Healthy individuals
5. Individuals whose TEWL is relatively high at screening (Scr)
1. Individuals who are receiving treatment for or have a history of malignant tumors, heart failure, or myocardial infarction
2. Individuals who have an implanted pacemaker or implantable cardioverter defibrillator
3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
4. Individuals who consume Foods for Specified Health Uses or Foods with Functional Claims
5. Individuals who are taking or using medications (including herbal medicines) or supplements
6. Individuals who are allergic to medications or foods related to the test product, particularly those allergic to soy beans
7. Individuals who are pregnant, lactating, or planning pregnancy during this study
8. Individuals who have participated in other clinical studies within 28 days before informed consent, or plan to participate in another study during this study
9. Individuals who have irregular lifestyles (such as diet, exercise, and sleep)
10. Individuals who are undergoing medical treatment for chronic fatigue syndrome or menopausal syndrome
11. Individuals who have been diagnosed with atopic dermatitis, and Individuals with a history of skin diseases that could potentially affect the assessment on this study
12. Individuals who habitually receive skincare treatment (e.g., aesthetic treatment) or use instruments for beauty treatment (e.g., facial treatment device)
13. Individuals who have undergone cosmetic surgery
14. Individuals who are deemed unsuitable for participation in this study by the principal investigator
20
| 1st name | Tsuyoshi |
| Middle name | |
| Last name | Takara |
Medical Corporation Seishinkai, Takara Clinic
Director
141-0022
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
t-takara@takara-clinic.com
| 1st name | Naoko |
| Middle name | |
| Last name | Suzuki |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan
03-3818-0610
nao@orthomedico.jp
SPIC Corporation
SPIC Corporation
Profit organization
The ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
IRB@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
南町医院 (東京都)
Nerima Medical Association, Minami-machi Clinic (Tokyo, Japan)
| 2026 | Year | 11 | Month | 20 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 11 | Month | 11 | Day |
| 2026 | Year | 11 | Month | 11 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
| 2027 | Year | 03 | Month | 29 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072909